Safety study of KT-579 in healthy volunteers
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult.
- Your weight must be at least 110 pounds (50 kg) if male or 88 pounds (40 kg) if female.
- Your body mass index (BMI) must be between 18 and 32.
- You must not have any major medical conditions or take certain medications.
- You must agree to use birth control (if applicable) and not donate sperm or eggs during the study.
- You cannot be pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication, KT-621, given as different tablet or capsule forms. It helps researchers understand how the body handles the drug, which is the first step toward future treatments.
This trial is testing a new medicine called KHN707 in healthy people. The goal is to see if it is safe and how the body handles it. It is an early-stage study, so it is not intended to treat any condition yet.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
This study tests a new medicine called KHN702 in healthy volunteers to see how the body processes it and whether it is safe. It is an early-stage trial, so participants will help find out how the drug works before it is studied in patients.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.